Spectrum of Phosphatidylinositol 3-Kinase Pathway Gene Alterations in Bladder Cancer

PI3K pathway alterations are common in bladder cancer. The lack of redundancy of alterations suggests that single-agent PI3K-targeted therapy may not be successful in these cancers. This study provides a well-characterized series of cell lines for use in preclinical studies of targeted agents.